Now researchers, led by Chad Roy, PhD, MSPH, from Tulane University, have used the South African Airborne Infections Research ...

Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

A new study reveals evidence that immune cells, liver cells and viral leftovers created a dangerous combination.

New research links multisystem inflammatory syndrome in children with COVID-19 to Epstein-Barr virus reactivation, revealing ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...

Following viral challenge with SARS-CoV-2 XBB.1.5, lung tissue samples were collected three days post-infection to quantify ...

The following is a summary of “A viro-immunological model to characterize the antiviral effect of molnupiravir in ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could ...

The technology's ability to rapidly and continuously inactivate viruses like SARS-CoV-2, RSV, and MPXV can significantly enhance ... it has evolved to reduce exposure to pathogens, including RNA and ...